SFE Stock Price, Safeguard Scientifics Quote, Chart

Market Summary

USD37.58

Market Closed

SFE Stock Price

View Fullscreen

SFE RSI Chart

SFE Valuation

Market Cap

628.5M

Price/Earnings (Trailing)

-63.94

EV/EBITDA

-62.98

Price/Free Cashflow

-189.98

MarketCap/EBT

-63.94

SFE Price/Sales (Trailing)

SFE Profitability

Return on Equity

-49.19%

Return on Assets

-43.04%

Free Cashflow Yield

-0.53%

SFE Fundamentals

SFE Earnings

Earnings (TTM)

-9.8M

Earnings Growth (Yr)

9.42%

Earnings Growth (Qtr)

-573.61%

Breaking Down SFE Revenue

Last 7 days

-2.2%

Last 30 days

-3.9%

Last 90 days

11.7%

Trailing 12 Months

38.7%

How does SFE drawdown profile look like?

SFE Financial Health

Current Ratio

4.84

SFE Investor Care

Buy Backs (1Y)

22.48%

Diluted EPS (TTM)

-0.61

Tracking the Latest Insider Buys and Sells of Safeguard Scientifics Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Jan 30, 2024	demont ross d	acquired	14,750	0.71	20,775	-
Jan 30, 2024	michelson beth	acquired	15,979	0.71	22,506	-
Jan 30, 2024	manko joseph m. jr.	acquired	27,041	0.71	38,087	-
Jan 30, 2024	glass russell d	acquired	14,750	0.71	20,775	-
Dec 15, 2023	salzman eric	acquired	-	-	125,000	chief executive officer
Dec 15, 2023	salzman eric	sold (taxes)	-71,054	1.0319	-68,858	chief executive officer
Nov 15, 2023	salzman eric	sold (taxes)	-5,297	0.9962	-5,318	chief executive officer
Oct 16, 2023	salzman eric	sold (taxes)	-5,880	1.11	-5,298	chief executive officer
Oct 16, 2023	glass russell d	acquired	15,903	1.11	14,327	-
Oct 16, 2023	manko joseph m. jr.	acquired	29,155	1.11	26,266	-

Which funds bought or sold SFE recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 02, 2024	NJ State Employees Deferred Compensation Plan	sold off	-100	-16,475	-	-%
May 01, 2024	Key Financial Inc	sold off	-100	-50.00	-	-%
May 01, 2024	CONCOURSE FINANCIAL GROUP SECURITIES, INC.	sold off	-	-	-	-%
Apr 26, 2024	SALZHAUER MICHAEL	sold off	-100	-11,705	-	-%
Apr 25, 2024	Bank of New York Mellon Corp	sold off	-100	-10,948	-	-%
Apr 24, 2024	BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC	sold off	-100	-406	-	-%
Apr 09, 2024	Rise Advisors, LLC	sold off	-100	-21.00	-	-%
Apr 09, 2024	Rise Advisors, LLC	new	-	29.00	29.00	-%
Mar 11, 2024	VANGUARD GROUP INC	reduced	-4.59	-174,255	518,668	-%
Feb 16, 2024	Madison Avenue Partners, LP	reduced	-26.47	-151,939	207,146	0.03%

Are Funds Buying or Selling SFE?

Are funds buying SFE calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own SFE

No. of Funds

Unveiling Safeguard Scientifics Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	halis family foundation	5.1%	843,311	SC 13G/A
Feb 14, 2024	satterfield thomas a jr	12.61%	2,089,726	SC 13G/A
Feb 12, 2024	first manhattan co. llc.	3.94%	652,704	SC 13G/A
Jan 26, 2024	yakira capital management, inc.	2.26%	375,060	SC 13G/A
Jan 22, 2024	halis family foundation	5.0%	828,790	SC 13G
Jan 02, 2024	exploration capital, llc	5.1%	852,460	SC 13G
Feb 14, 2023	first manhattan co	7.32%	1,194,142	SC 13G/A
Feb 13, 2023	north run capital, lp	1.5%	252,728	SC 13G/A
Feb 13, 2023	contrarian capital management, l.l.c.	7.4%	1,199,204	SC 13G
Feb 10, 2023	satterfield thomas a jr	11.39%	1,859,281	SC 13G/A

Recent SEC filings of Safeguard Scientifics Inc

View All Filings

Date Filed	Form Type	Document
Mar 26, 2024	10-K	Annual Report
Feb 20, 2024	15-12G	15-12G
Feb 20, 2024	SC 13E3/A	SC 13E3/A
Feb 16, 2024	EFFECT	EFFECT
Feb 14, 2024	SC 13G/A	Major Ownership Report
Feb 14, 2024	SC 13G/A	Major Ownership Report
Feb 12, 2024	8-K	Current Report
Feb 12, 2024	SC 13G/A	Major Ownership Report
Feb 09, 2024	S-8 POS	Employee Benefits Plan
Feb 09, 2024	POS AM	POS AM

Peers (Alternatives to Safeguard Scientifics Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
BLK	113.8B	17.9B	-6.25%	20.94%	20.68	6.37	-0.08%	6.26%
BX	84.3B	10.3B	-6.78%	46.19%	39.17	8.16	116.39%	249.10%
BK	42.6B	19.6B	-1.14%	42.22%	12.77	2.17	78.39%	20.24%
ARES	40.6B	3.6B	-0.08%	65.82%	85.52	11.17	18.87%	183.11%
BEN	12.3B	8.1B	-14.98%	-6.85%	13.69	1.52	2.98%	5.84%
MID-CAP
IVZ	6.7B	5.8B	-11.09%	-6.41%	-19.78	1.16	-1.10%	-153.42%
AMG	5.3B	2.1B	-3.58%	16.39%	7.81	2.56	-11.67%	-41.28%
AB	3.8B	-	-4.52%	1.91%	13.93	-	-	7.16%
CNS	3.6B	486.3M	-4.17%	30.11%	27.92	7.33	-9.75%	-22.27%
APAM	3.4B	1.0B	-6.54%	33.00%	14.71	3.38	6.21%	20.27%
AMK	2.5B	708.5M	-0.85%	29.08%	20.52	3.57	15.83%	19.23%
SMALL-CAP
PX	878.9M	241.7M	-9.45%	-25.05%	-127.72	3.64	21.87%	-123.56%
BSIG	862.0M	426.6M	-2.04%	-	13.1	2.02	2.25%	-34.59%
AINC	16.6M	746.8M	3.41%	-52.22%	-3.6	0.02	15.88%	-226.93%
AC	697.8K	25.3M	0.93%	-13.58%	0.02	0.03	137.10%	176.58%

Safeguard Scientifics Inc News

Latest updates

Safeguard Scientifics Inc Earnings Report: Key Takeaways & Analysis

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	-29.6%	23.00	32.00	31.00	34.00	38.00	43.00	46.00	46.00	54.00	104	85.00	87.00	69.00	76.00	80.00	92.00	108	131	181	170	146
Current Assets	-39.1%	10.00	16.00	17.00	20.00	21.00	24.00	21.00	23.00	30.00	76.00	45.00	22.00	16.00	17.00	14.00	22.00	26.00	48.00	102	82.00	47.00
Cash Equivalents	-39.3%	9.00	16.00	14.00	11.00	13.00	15.00	18.00	19.00	25.00	64.00	21.00	22.00	16.00	16.00	14.00	21.00	25.00	46.00	73.00	45.00	8.00
Net PPE	-	-	-	-	-	-	-	-	-	-	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	1.00
Liabilities	14.2%	3.00	3.00	2.00	2.00	3.00	3.00	3.00	3.00	3.00	6.00	5.00	6.00	6.00	6.00	5.00	7.00	6.00	8.00	56.00	82.00	79.00
Current Liabilities	30.9%	2.00	2.00	1.00	1.00	2.00	2.00	1.00	1.00	2.00	4.00	3.00	4.00	3.00	3.00	2.00	3.00	2.00	4.00	52.00	77.00	33.00
LT Debt, Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Shareholder's Equity	-33.2%	20.00	30.00	29.00	31.00	35.00	40.00	43.00	44.00	51.00	98.00	79.00	81.00	63.00	70.00	74.00	86.00	102	123	125	89.00	67.00
Retained Earnings	-0.6%	-733	-729	-730	-727	-723	-719	-715	-716	-709	-701	-719	-719	-736	-729	-724	-713	-697	-675	-673	-709	-731
Additional Paid-In Capital	-0.9%	794	801	801	803	805	805	805	806	807	807	806	807	808	809	809	811	811	811	810	811	811
Shares Outstanding	-24.8%	16.00	22.00	22.00	22.00	16.00	22.00	22.00	22.00	20.00	21.00	21.00	21.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	21.00	-	-	-	50.00	-	-	-	155	-	-	-	136	-	-	-	237	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	-90.7%	-818	-429	-1,133	-928	-598	-561	-1,098	-1,001	-2,708	-710	-2,577	-2,157	-1,118	-1,250	-3,224	-2,551	-1,427	-6,362	-6,399	-5,782	-7,386
Cashflow From Investing	-70.4%	551	1,863	4,397	-1,090	-199	-1,548	187	-3,102	2,273	43,690	3,732	8,419	292	4,063	-4,091	-1,533	1,621	23,030	58,807	42,845	-12,467
Cashflow From Financing	-29405.0%	-5,901	-20.00	-26.00	-305	-905	-368	-986	-1,229	-39,037	-74.00	-1,600	-88.00	-10.00	-8.00	-11.00	-11.00	-20,705	-44,574	-24,055	-149	-16,466
Buy Backs	-	-	-	-	75.00	879	337	944	779	39,016	51.00	1,588	-	-	-	-	-	-	-	-	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

SFE Income Statement

2023-12-31

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
General and administrative expense	$ 5,683	$ 4,775
Operating loss	(5,683)	(4,775)
Other income (loss), net	2,037	(3,297)
Interest income	903	794
Equity (loss), net	(7,085)	(6,985)
Net (loss) before income taxes	(9,828)	(14,263)
Income tax benefit (expense)	0	0
Net (loss)	$ (9,828)	$ (14,263)
Net (loss) per share:
Basic (in dollars per share)	$ (0.61)	$ (0.87)
Diluted (in dollars per share)	$ (0.61)	$ (0.87)
Weighted average shares used in computing net (loss) per share:
Basic (in shares)	16,221	16,337
Diluted (in shares)	16,221	16,337

SFE Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current Assets:
Cash and cash equivalents	$ 9,498	$ 13,331
Restricted cash	19	25
Marketable securities	0	5,956
Ownership interests	0	860
Prepaid expenses and other current assets	394	1,251
Total current assets	9,911	21,423
Right-of-use asset, net	971	1,290
Ownership interests and advances	11,691	14,545
Other assets	263	434
Total Assets	22,836	37,692
Current Liabilities:
Accounts payable	107	16
Accrued compensation and benefits	854	507
Accrued expenses and other current liabilities	596	865
Lease liability - current	489	429
Total current liabilities	2,046	1,817
Lease liability - non-current	760	1,249
Other long-term liabilities	50	50
Total Liabilities	2,856	3,116
Commitments and contingencies (Note 11)
Equity:
Preferred stock, $0.10 par value; 1,000 shares authorized	0	0
Common stock, $0.10 par value; 83,333 shares authorized; 21,573 issued at December 31, 2023 and 2022, respectively	2,157	2,157
Additional paid-in capital	793,992	804,752
Treasury stock, at cost; 4,947 and 5,478 shares at December 31, 2023 and 2022, respectively	(42,418)	(48,410)
Accumulated deficit	(733,726)	(723,898)
Accumulated other comprehensive loss	(25)	(25)
Total Equity	19,980	34,576
Total Liabilities and Equity	$ 22,836	$ 37,692

About Safeguard Scientifics Inc

Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector. Within the technology sector, it invests in software as a service, adtech / digital media, Internet of Everything, enhanced security, predictive analytics, machine learning, artificial intelligence, enterprise software, technology enabled services, internet/new media, financial technology, cloud, mobile, social, big data, in memory, and selected business services with capital requirements of up to $25 million. Within healthcare sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, medical technology, digital health, healthcare technology, specialty pharmaceuticals, and selected healthcare services. It invests throughout the United States with a focus on Mid-Atlantic region, and Southeastern Canada. The firm primarily invests between $5 million and $25 million in growth equity financing and between $5 million and $10 million in early-stage financing. It typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, and venture capital-backed seeking a growth partner. The firm prefers to be the largest shareholder in its portfolio companies, with ownership in the range of 20 percent to 50 percent. However, it may occasionally take a majority or smaller stake in its portfolio companies. It prefers to invest in companies having proprietary technology and intellectual property. The firm prefers to take a Board seat in its portfolio companies. The company was founded in 1953 as Lancaster Corporation and changed its name to Safeguard Scientifics, Inc. in 1981. Safeguard Scientifics, Inc. is based in Radnor, Pennsylvania with additional office in Weston, Massachusetts.

0

WEBSITE	safeguard.com
INDUSTRY	Asset Management

Safeguard Scientifics Inc Frequently Asked Questions

What is the ticker symbol for Safeguard Scientifics Inc? What does SFE stand for in stocks?

SFE is the stock ticker symbol of Safeguard Scientifics Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Safeguard Scientifics Inc (SFE)?

As of Mon Apr 22 2024, market cap of Safeguard Scientifics Inc is 628.45 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SFE stock?

You can check SFE's fair value in chart for subscribers.

What is the fair value of SFE stock?

You can check SFE's fair value in chart for subscribers. The fair value of Safeguard Scientifics Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Safeguard Scientifics Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for SFE so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Safeguard Scientifics Inc a good stock to buy?

The fair value guage provides a quick view whether SFE is over valued or under valued. Whether Safeguard Scientifics Inc is cheap or expensive depends on the assumptions which impact Safeguard Scientifics Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SFE.

What is 5 year return on Safeguard Scientifics Inc's stock?

In the past 10 years, Safeguard Scientifics Inc has provided 0.076 (multiply by 100 for percentage) rate of return.